Michael D Taylor Selected Research

Ependymoma

1/2022	The biology of ependymomas and emerging novel therapies.
1/2021	Reevaluating surgery and re-irradiation for locally recurrent pediatric ependymoma-a multi-institutional study.
11/2020	Metabolic Regulation of the Epigenome Drives Lethal Infantile Ependymoma.
10/2020	Genetic predisposition to longer telomere length and risk of childhood, adolescent and adult-onset ependymoma.
1/2020	Locoregional delivery of CAR T cells to the cerebrospinal fluid for treatment of metastatic medulloblastoma and ependymoma.
1/2019	Infusion of 5-Azacytidine (5-AZA) into the fourth ventricle or resection cavity in children with recurrent posterior Fossa Ependymoma: a pilot clinical trial.
1/2019	Craniospinal irradiation as part of re-irradiation for children with recurrent intracranial ependymoma.
12/2018	Significance of molecular classification of ependymomas: C11orf95-RELA fusion-negative supratentorial ependymomas are a heterogeneous group of tumors.
1/2018	Therapeutic targeting of ependymoma as informed by oncogenic enhancer profiling.
1/2018	Molecular heterogeneity and CXorf67 alterations in posterior fossa group A (PFA) ependymomas.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Michael D Taylor Research Topics

Disease

150	Neoplasms (Cancer) 01/2022 - 09/2003
140	Medulloblastoma 05/2022 - 09/2003
37	Brain Neoplasms (Brain Tumor) 10/2020 - 11/2003
22	Ependymoma 01/2022 - 10/2009
14	Glioma (Gliomas) 01/2021 - 01/2014
12	Neoplasm Metastasis (Metastasis) 01/2022 - 04/2012
11	Glioblastoma (Glioblastoma Multiforme) 11/2021 - 10/2012
10	Carcinogenesis 01/2022 - 04/2009
10	Cardiomyopathies (Cardiomyopathy) 10/2021 - 01/2007
9	Duchenne Muscular Dystrophy (Muscular Dystrophy, Becker) 12/2022 - 10/2011
8	Fibrosis (Cirrhosis) 10/2020 - 06/2002
8	Inflammation (Inflammations) 01/2014 - 04/2003
7	Primitive Neuroectodermal Tumors (PNET) 01/2019 - 12/2009
7	Astrocytoma (Pilocytic Astrocytoma) 01/2018 - 08/2013
4	Hypoxia (Hypoxemia) 11/2020 - 03/2008
4	Infections 11/2004 - 11/2003
4	Lung Injury 02/2004 - 02/2003
3	Tics (Tic) 01/2019 - 09/2014
3	Hypertension (High Blood Pressure) 09/2017 - 04/2006
3	Diffuse Intrinsic Pontine Glioma 01/2017 - 12/2014
3	Infarction (Infarctions) 02/2016 - 01/2007
3	Tuberous Sclerosis (Bourneville's Disease) 10/2015 - 09/2009
3	Carcinoma (Carcinomatosis) 08/2015 - 07/2014
3	AIDS-Related Complex (ARC) 11/2005 - 09/2003
3	Bacterial Infections (Bacterial Infection) 11/2004 - 11/2003
2	Hypersensitivity (Allergy) 12/2022 - 02/2015
2	Rhabdoid Tumor (Rhabdoid Tumors) 01/2022 - 11/2019
2	Aneurysm (Aneurysms) 01/2021 - 10/2011
2	Turcot syndrome 01/2021 - 06/2004
2	Intracranial Aneurysm (Cerebral Aneurysm) 01/2021 - 10/2011
2	Microsatellite Instability 01/2021 - 11/2017
2	Genomic Instability 12/2019 - 01/2003
2	Melanoma (Melanoma, Malignant) 01/2019 - 04/2008
2	Hydrocephalus (Hydrocephaly) 01/2019 - 06/2014
2	Choroid Plexus Carcinoma 01/2019 - 06/2010
2	Choroid Plexus Neoplasms (Choroid Plexus Tumor) 01/2019 - 01/2015

Drug/Important Bio-Agent (IBA)

31	Proteins (Proteins, Gene)FDA Link 01/2022 - 09/2003
24	Biomarkers (Surrogate Marker)IBA 01/2022 - 12/2009
18	Biological ProductsIBA 01/2022 - 07/2011
16	MicroRNAs (MicroRNA)IBA 01/2019 - 01/2009
15	DNA (Deoxyribonucleic Acid)IBA 11/2021 - 09/2003
15	RNA (Ribonucleic Acid)IBA 01/2021 - 01/2010
14	Phosphotransferases (Kinase)IBA 01/2019 - 11/2013
13	Messenger RNA (mRNA)IBA 01/2021 - 10/2010
12	Pharmaceutical PreparationsIBA 01/2022 - 06/2002
9	Histones (Histone)IBA 12/2020 - 04/2009
9	Formaldehyde (Formol)FDA Link 01/2020 - 04/2011
8	ChromatinIBA 11/2021 - 06/2014
8	GadoliniumIBA 02/2021 - 11/2003
7	ParaffinIBA 01/2020 - 04/2012
6	Telomerase (Telomerase Reverse Transcriptase)IBA 11/2021 - 12/2013
5	ProteomeIBA 01/2022 - 06/2015
5	NucleotidesIBA 11/2021 - 07/2017
5	Stainless Steel (Steel, Stainless)IBA 01/2006 - 09/2003
4	Ion Channels (Ion Channel)IBA 01/2020 - 08/2012
4	Small Interfering RNA (siRNA)IBA 01/2018 - 06/2010
4	MetalsIBA 11/2005 - 09/2003
3	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2022 - 11/2004
3	DNA-Directed DNA Polymerase (Polymerases, DNA)IBA 01/2021 - 03/2015
3	Lysine (L-Lysine)FDA Link 11/2020 - 04/2009
3	Mitogen-Activated Protein KinasesIBA 06/2020 - 08/2013
3	Azacitidine (5 Azacytidine)FDA Link 01/2020 - 01/2010
3	CateninsIBA 01/2020 - 11/2010
3	AntibodiesIBA 01/2019 - 04/2008
3	Adapalene (Differin)FDA LinkGeneric 01/2018 - 04/2013
3	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 09/2017 - 01/2007
3	Pyruvate KinaseIBA 01/2017 - 06/2015
3	hydrogen sulfite (bisulfite)IBA 10/2016 - 01/2010
3	Cisplatin (Platino)FDA LinkGeneric 10/2016 - 03/2014
3	Complementary DNA (cDNA)IBA 11/2004 - 09/2003
2	Small Cytoplasmic RNAIBA 05/2022 - 12/2019
2	Oxygen (Dioxygen)IBA 01/2022 - 11/2020
2	Clostridium perfringens epsilon-toxinIBA 01/2022 - 01/2018
2	DystrophinIBA 10/2021 - 04/2015
2	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 01/2021 - 01/2018
2	Glycine (Aminoacetic Acid)FDA LinkGeneric 12/2020 - 12/2020
2	Nerve Growth Factors (Neurotrophins)IBA 09/2020 - 01/2019
2	Potassium Channels (Potassium Channel)IBA 01/2020 - 09/2015
2	Cathepsin BIBA 01/2020 - 01/2013
2	Antineoplastic Agents (Antineoplastics)IBA 01/2020 - 07/2014
2	AntigensIBA 01/2020 - 04/2008
2	Desmoplakins (Desmoplakin)IBA 01/2020 - 09/2006
2	Activated-Leukocyte Cell Adhesion Molecule (Neurolin)IBA 01/2020 - 01/2018
2	HhAntag691IBA 12/2019 - 01/2018
2	U1 small nuclear RNAIBA 10/2019 - 10/2019
2	Transcription Factors (Transcription Factor)IBA 02/2019 - 01/2018
2	cytidylyl-(3'-5')-cytidine (CpC)IBA 01/2019 - 01/2015
2	Antipsychotic Agents (Antipsychotics)IBA 01/2019 - 09/2015
2	LipidsIBA 01/2019 - 09/2006

Therapy/Procedure

97	Therapeutics 12/2022 - 09/2003
23	Drug Therapy (Chemotherapy) 03/2019 - 04/2008
13	Radiotherapy 01/2021 - 03/2010
7	Craniospinal Irradiation 01/2019 - 06/2014
6	Immunotherapy 01/2022 - 01/2018
4	Re-Irradiation 01/2021 - 08/2012
4	Transplantation 01/2019 - 02/2012
3	Lasers (Laser) 01/2019 - 06/2002
2	Stem Cell Transplantation 01/2022 - 06/2021
2	Arterial Switch Operation 01/2021 - 04/2008
2	Chemoradiotherapy 01/2020 - 01/2016